Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Ellomay Capital Reports Results for the Three Months Ended March 31, 2021


      News provided by

      Ellomay Capital Ltd

      Jun 24, 2021, 17:10 ET

      Share this article

      Share this article


      TEL AVIV, Israel, June 24, 2021 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported unaudited financial results for the three month period ended March 31, 2021.

      Financial Highlights

      • Revenues were approximately €7.2 million for the three months ended March 31, 2021, compared to approximately €1.9 million for the three months ended March 31, 2020. This increase is mainly attributable to the achievement of PAC (Preliminary Acceptance Certificate) of the Talasol photovoltaic facility (the "Talasol PV Plant") on January 27, 2021, upon which the Company commenced recognition of revenues. The increase also resulted from the acquisition of the Groen Gas Gelderland B.V. biogas facility (the "Gelderland Biogas Plant") in December 2020 and improved operational efficiency at the Company's biogas plants in the Netherlands.
      • Operating expenses were approximately €3.2 million for the three months ended March 31, 2021, compared to approximately €1.1 million for the three months ended March 31, 2020. Depreciation expenses were approximately €3.1 million for the three months ended March 31, 2021, compared to approximately €0.7 million for the three months ended March 31, 2020. The increase in operating expenses and in depreciation expenses is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the Gelderland Biogas Plant acquisition in December 2020.
      • Project development costs were approximately €0.5 million for the three months ended March 31, 2021, compared to approximately €1.8 million for the three months ended March 31, 2020. The decrease in project development costs is mainly due to capitalization of expenses in connection with the pumped-hydro storage project in the Manara Cliff commencing the fourth quarter of 2020.
      • General and administrative expenses were approximately €1.3 million for the three months ended March 31, 2021, compared to approximately €1.1 million for the three months ended March 31, 2020. There was no material change in the composition of the expenses included in general and administrative expenses between the two periods.
      • Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €0.6 million for the three months ended March 31, 2021, compared to approximately €1.3 million for the three months ended March 31, 2020. The decrease in the Company's share of profit of equity accounted investee is mainly attributable to the decrease in Dorad Energy Ltd.'s revenues.
      • Financing expenses, net were approximately €2.8 million for the three months ended March 31, 2021, compared to approximately €0.4 million for the three months ended March 31, 2020. The increase in financing expenses, net, was mainly attributable to €0.8 million of expenses due to the early repayment of the Company's Series B Debentures and financing expenses in connection with the Talasol PV Plant previously capitalized to fixed assets that are recognized in profit and loss starting from PAC.
      • Tax benefits were approximately €0.3 million for the three months ended March 31, 2021, compared to taxes on income of approximately €0.1 million for the three months ended March 31, 2020.
      • Loss for the three months ended March 31, 2021 was approximately €2.7 million, compared to a loss of approximately €1.9 million for the three months ended March 31, 2020.
      • Total other comprehensive loss was approximately €2.4 million for the three months ended March 31, 2021, compared to other comprehensive income of approximately €14 million for the three months ended March 31, 2020. The decrease in total other comprehensive income mainly resulted from changes in fair value of cash flow hedges.
      • Total comprehensive loss was approximately €5 million for the three months ended March 31, 2021, compared to total comprehensive income of approximately €12.1 million for the three months ended March 31, 2020.
      • EBITDA was approximately €2.9 million for the three months ended March 31, 2021, compared to EBITDA loss of approximately €(0.6) million for the three months ended March 31, 2020. See the table on page 12 of this press release for a reconciliation of these numbers to profit and loss.
      • Net cash provided by operating activities was approximately €1.3 million for the three months ended March 31, 2021, compared to net cash used in operating activities of approximately €0.5 million for the three months ended March 31, 2020. The increase is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the Gelderland Biogas Plant acquisition in December 2020.
      • As of June 1, 2021, the Company held approximately €78 million in cash and cash equivalents and approximately €9.8 million in restricted short-term and long-term cash.

      CEO Review – First Quarter of 2021

      The financial results for the first quarter of 2021 included first time results of the Talasol PV Plant (300 MW photovoltaic plant in Spain) and the Gelderland Biogas Plant (which has a green gas production license of 7.5 million Nm3 per year). The results of the quarter reflect an increase of approximately 270% in revenues and net cash from operating activities changed from loss in the first quarter of 2020 to profit.

      During the first quarter the pumped hydro-storage project in the Manara Cliff, Israel (156MWh with an aggregate storage capacity of approximately 1,900 MWh), achieved financial closing and as of today the building works have commenced. In addition, we received the construction permits for the Ellomay Solar project (28 MW photovoltaic plant in Spain) and the building works are in progress.

      In parallel to the operations of the existing portfolio and the management of the projects under construction, the Company is advancing the development of a pipeline of photovoltaic projects in Spain, Italy and Israel, which includes approximately 479 MW in advanced development stages and approximately 850 MW in preliminary development stages.

      Talasol PV Plant (300 MW photovoltaic plant in Spain)

      The proceeds from sale of electricity during the first quarter were approximately €4.1 and in line with the higher projected revenues for the first quarter of 2021. Based on applicable accounting rules, an amount of approximately €1 million of such proceeds (which represents revenues from the sale of electricity prior to January 27, 2021 (the date in which the Talasol PV Plant achieved PAC)) was not recognized as revenues and was capitalized and deducted from the cost of construction. The Adjusted FFO of the Talasol PV Plant for the quarter was approximately €1.8 million (including the period prior to January 27, 2021 of which the results were capitalized in accordance with applicable accounting rules). The efficiency of the Talasol PV Plant during the first quarter of 2021 was approximately 88.43%, compared to the constructor's contractual undertaking for a minimal efficiency of 76.95%.

      Biogas Segment – the Netherlands

      During the first quarter of 2021, the Company successfully completed the integration of the  Gelderland Biogas Plant. This plant is equal in size to the two other plants owned by the Company (combined) and is characterized by advanced manufacturing equipment. The existing equipment enables an increase of approximately 20% of production (subject to receipt of required permits) and the plant includes additional land owned by the project company which will enable additional expansion. The biogas segment of the Company produced revenues of approximately €3.1 million and contributed approximately €0.6 million of FFO during the first quarter of 2021. The Company has a plan for additional improvements and enhancements underway that includes improvements in the processes and the expansion of existing facilities.

      Photovoltaic Segment in Spain (7.9 MW subsidized by Spain)

      The results of these plants for the first quarter of 2021 were in line with the expectations and contributed revenues of approximately €0.8 million and FFO of approximately €0.7 million.

      Talmei Yosef PV Plant (9 MW photovoltaic plant in Israel)

      The results of the Talmei Yosef PV Plant for the first quarter of 2021 were in line with the expectations and contributed adjusted revenues of approximately €0.8 million (adjusted to present the revenues based on the fixed asset model and not as a financial asset under IFRIC 12) and Adjusted FFO of approximately €0.5 million.

      Dorad Power Plant (9.375% indirectly owned by the Company)

      The results of the Dorad power plant for the first quarter of 2021 were in line with expectations. The Company's share of the net profit was approximately €0.62 million.

      The 2021 first quarter's results of the Company, taking into account the results of the Talasol PV Plant for the period until January 27, 2021 that was not recognized in profit and loss, support the annual projections included in the Company's investor presentation published in May 2021.

      The Company's PV operations, including the Talasol PV Plant, are affected by seasonality. The first quarter is characterized by lower radiation resulting in relatively lower revenues. Therefore, the second quarter's revenues of the Company's PV operations are expected to be significantly higher. For example, commencing April 1, 2021 and until today, the Talasol PV Plant produced revenues in the amount of approximately €9 million.

      The financing expenses for the quarter included the cost of the early repayment of the Company's Series B debentures and the settlement of the related hedging transactions for an aggregate cost of approximately €1.1 million and its exchange for the Series C debentures that bear a lower interest rate will in the future compensate for the cost of the early repayment.

      Use of NON-IFRS Financial Measures

      EBITDA, FFO and Adjusted FFO are non-IFRS measures. EBITDA is defined as earnings before financial expenses, net, taxes, depreciation and amortization and FFO (funds from operations) and Adjusted FFO are calculated by adding depreciation and amortization expenses to operating profit (loss) and deducting interest expenses on loans. The Company uses the terms "Adjusted FFO" to highlight the fact that the Company presents the revenues from the Talmei Yosef PV Plant under the fixed asset model and not under IFRIC 12 and includes the financial results of the Talasol PV plant for the period prior to achievement of PAC that were not recognized in the profit and loss statement based on accounting rules. The Company presents these measures in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers these non-IFRS measures to be important measures of comparative operating performance, these non-IFRS measures should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. These non-IFRS measures do not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, are not necessarily indicative of amounts that may be available for discretionary uses. In addition, Adjusted FFO does not represent and is not an alternative to cash flow from operations as defined by IFRS and is not an indication of cash available to fund all cash flow needs, including the ability to make distributions. Not all companies calculate EBITDA, FFO or Adjusted FFO in the same manner, and the measures as presented may not be comparable to similarly-titled measures presented by other companies. The Company's actual EBITDA, FFO and Adjusted FFO may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses these measures internally as performance measures and believes that when these measures are combined with IFRS measures they add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 12 of this press release.

      About Ellomay Capital Ltd.

      Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

      To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

      • Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;
      • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel's total current electricity consumption;
      • 51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
      • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;
      • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.

      For more information about Ellomay, visit http://www.ellomay.com.

      Information Relating to Forward-Looking Statements

      This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements.  The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

      Contact:
      Kalia Weintraub
      CFO
      Tel: +972 (3) 797-1111
      Email: [email protected]

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Financial Position


      March 31

      December 31,

      March 31,


      2021

      2020

      2021


      Unaudited

      Audited

      Unaudited


      € in thousands

      Convenience Translation into
      US$ in thousands*
      *

      Assets




      Current assets:




      Cash and cash equivalents

      105,020

      66,845

      123,249

      Marketable securities

      -

      1,761

      -

      Short term deposits

      -

      8,113

      -

      Restricted cash

      2,500

      -

      2,934

      Receivable from concession project

      1,533

      1,491

      1,799

      Trade and other receivables

      9,071

      9,825

      10,646


      118,124

      88,035

      138,628

      Non-current assets




      Investment in equity accounted investee

      33,229

      32,234

      38,997

      Advances on account of investments

      2,430

      2,423

      2,852

      Receivable from concession project

      25,009

      25,036

      29,350

      Fixed assets

      278,363

      264,095

      326,680

      Right-of-use asset

      12,473

      17,209

      14,638

      Intangible asset

      4,552

      4,604

      5,342

      Restricted cash and deposits

      7,025

      9,931

      8,244

      Deferred tax

      4,896

      3,605

      5,746

      Long term receivables

      66

      2,762

      77

      Derivatives

      5,480

      10,238

      6,431


      373,523

      372,137

      438,357





      Total assets

      491,647

      460,172

      576,985





      Liabilities and Equity




      Current liabilities




      Current maturities of long term bank loans

      13,331

      10,232

      15,645

      Current maturities of long term loans

      3,549

      4,021

      4,165

      Debentures

      8,295

      10,600

      9,735

      Trade payables

      2,380

      12,387

      2,793

      Other payables

      10,232

      7,912

      12,008


      37,787

      45,152

      44,346

      Non-current liabilities




      Lease liability

      12,455

      17,299

      14,617

      Long-term loans

      151,988

      134,520

      178,369

      Other long-term bank loans

      54,015

      49,396

      63,391

      Debentures

      92,941

      72,124

      109,073

      Deferred tax

      7,982

      7,806

      9,367

      Other long-term liabilities

      4,351

      513

      5,106

      Derivatives

      6,308

      8,336

      7,403


      330,040

      289,994

      387,326

      Total liabilities

      367,827

      335,146

      431,672

      Equity




      Share capital

      25,578

      25,102

      30,018

      Share premium

      85,756

      82,401

      100,641

      Treasury shares

      (1,736)

      (1,736)

      (2,037)

      Transaction reserve with non-controlling Interests

      5,145

      6,106

      6,038

      Reserves

      3,052

      4,164

      3,582

      Retained earnings

      6,122

      8,191

      7,185

      Total equity attributed to shareholders of the Company

      123,917

      124,228

      145,427

      Non-Controlling Interest

      (97)

      798

      (114)

      Total equity

      123,820

      125,026

      145,313

      Total liabilities and equity

      491,647

      460,172

      576,985


      * Convenience translation into US$ (exchange rate as at March 31, 2021: euro 1 = US$ 1.174)


       

       


      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Comprehensive Profit (Loss)



      For the three months
      ended March 31,

      For the year ended
      December 31,

      For the three months
      ended March 31,



      2021

      2020

      2020

      2021


      Unaudited

      Audited

      Unaudited


       

       

      € in thousands*

       

       

      € in thousands*

      Convenience
      Translation into
      US$** in thousands*

      Revenues

      7,200

      1,943

      9,645

      8,450

      Operating expenses

      (3,217)

      (1,061)

      (4,951)

      (3,775)

      Depreciation and amortization

      (3,051)

      (726)

      (2,975)

      (3,581)

      Gross profit

      932

      156

      1,719

      1,094






      Project development costs

      (505)

      (1,754)

      (3,491)

      (593)

      General and administrative expenses

      (1,263)

      (1,081)

      (4,512)

      (1,482)

      Share of profits of equity accounted investee

      617

      1,331

      1,525

      724

      Other expenses, net

      -

      -

      2,100

      -

      Operating loss

      (219)

      (1,348)

      (2,659)

      (257)






      Financing income

      912

      425

      2,134

      1,070

      Financing income in connection with derivatives, net

      (124)

      954

      1,094

      (146)

      Financing expenses

      (3,554)

      (1,792)

      (6,862)

      (4,171)

      Financing expenses, net

      (2,766)

      (413)

      (3,634)

      (3,247)

      Loss before taxes on income

      (2,985)

      (1,761)

      (6,293)

      (3,504)

      Tax benefit (Taxes on income)

      319

      (104)

      125

      374

      Loss for the period

      (2,666)

      (1,865)

      (6,168)

      (3,130)

      Loss attributable to:





      Owners of the Company

      (2,069)

      (1,417)

      (4,627)

      (2,428)

      Non-controlling interests

      (597)

      (448)

      (1,541)

      (702)

      Loss for the period

      (2,666)

      (1,865)

      (6,168)

      (3,130)

      Other comprehensive income (loss) items that after





      initial recognition in comprehensive income (loss)





      were or will be transferred to profit or loss:





      Foreign currency translation differences for foreign operations

      562

      (199)

      (482)

      660

      Effective portion of change in fair value of cash flow hedges

      (1,929)

      14,112

      2,210

      (2,264)

      Net change in fair value of cash flow hedges transferred to profit or loss

      (1,004)

      103

      555

      (1,178)

      Total other comprehensive income (loss)

      (2,371)

      14,016

      2,283

      (2,782)






      Total other comprehensive  income (loss) attributable to:





      Owners of the Company

      (1,112)

      6,901

      881

      (1,305)

      Non-controlling interests

      (1,259)

      7,115

      1,402

      (1,477)

      Total other comprehensive income (loss) for the period

      (2,371)

      14,016

      2,283

      (2,782)

      Total comprehensive income (loss) for the period

      (5,037)

      12,151

      (3,885)

      (5,912)






      Total comprehensive income (loss) attributable to:





      Owners of the Company

      (3,181)

      5,484

      (3,746)

      (3,733)

      Non-controlling interests

      (1,856)

      6,667

      (139)

      (2,179)

      Total comprehensive income (loss) for the period

      (5,037)

      12,151

      (3,885)

      (5,912)






      Basic net loss per share

      (0.16)

      (0.12)

      (0.38)

      (0.19)

      Diluted net loss per share

      (0.16)

      (0.12)

      (0.38)

      (0.19)


      * Except per share data

      ** Convenience translation into US$ (exchange rate as at March 31, 2021: euro 1 = US$ 1.174)


      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity




      Attributable to shareholders of the Company

      Non- controlling

      Total




      Interests

      Equity


      Share
      capital

      Share
      premium

       

       

      Retained
      earnings

      Treasury
      shares

      Translation
      reserve from

      foreign
      operations

      Hedging
      Reserve

      Interests
      Transaction
      reserve with

      non-controlling
      Interests

      Total




      € in thousands

      For the three month ended March 31, 2021 (unaudited):











      Balance as at January 1, 2021

      25,102

      82,401

      8,191

      (1,736)

      3,823

      341

      6,106

      124,228

      798

      125,026

      Loss for the period

      -

      -

      (2,069)

      -

      -

      -

      -

      (2,069)

      (597)

      (2,666)

      Other comprehensive income (loss) for the period

      -

      -

      -

      -

      558

      (1,670)

      -

      (1,112)

      (1,259)

      (2,371)

      Total comprehensive income (loss) for the period

      -

      -

      (2,069)

      -

      558

      (1,670)

      -

      (3,181)

      (1,856)

      (5,037)

      Transactions with owners of the Company,  recognized directly in equity:











      Buy of shares in subsidiaries from non-controlling interests

      -

      -

      -

      -

      -

      -

      (961)

      (961)

      961

      -

      Warrants exercise

      454

      3,348

      -

      -

      -

      -

      -

      3,802

      -

      3,802

      Options exercise

      22

      -

      -

      -

      -

      -

      -

      22

      -

      22

      Share-based payments

      -

      7

      -

      -

      -

      -

      -

      7

      -

      7

      Balance as at











       March 31, 2021

      25,578

      85,756

      6,122

      (1,736)

      4,381

      (1,329)

      5,145

      123,917

      (97)

      123,820




      Attributable to shareholders of the Company

      Non- controlling

      Total




      Interests

      Equity


      Share capital

      Share premium

       

       

      Retained earnings

      Treasury shares

      Translation reserve from

      foreign operations

      Hedging Reserve

      Interests Transaction reserve with

      non-controlling Interests

      Total




      € in thousands

      For the three month ended March 31, 2020 (unaudited):











      Balance as at January 1, 2020

      21,998

      64,160

      12,818

      (1,736)

      4,356

      (1,073)

      6,106

      106,629

      937

      107,566

      Loss for the period

      -

      -

      (1,417)

      -

      -

      -

      -

      (1,417)

      (448)

      (1,865)

      Other comprehensive income (loss) for the period

      -

      -

      -

      -

      (223)

      7,124

      -

      6,901

      7,115

      14,016

      Total comprehensive income (loss) for the period

      -

      -

      (1,417)

      -

      (223)

      7,124

      -

      5,484

      6,667

      12,151

      Transactions with owners of the Company,  recognized directly in equity:











      Issuance of ordinary shares

      1,935

      11,253

      -

      -

      -

      -

      -

      13,188

      -

      13,188

      Share-based payments

      -

      14

      -

      -

      -

      -

      -

      14

      -

      14

      Balance as at











       March 31, 2020

      23,933

      75,427

      11,401

      (1,736)

      4,133

      6,051

      6,106

      125,315

      7,604

      132,919

       

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




      Attributable to shareholders of the Company

      Non- controlling

      Total




      Interests

      Equity













      Share capital

      Share premium

       

       

      Retained earnings

      Treasury shares

      Translation reserve from

      foreign operations

      Hedging Reserve

      Interests Transaction reserve with

      non-controlling Interests

      Total




      € in thousands

      For the year ended











      December 31, 2020 (Audited):











      Balance as at January 1, 2020

      21,998

      64,160

      12,818

      (1,736)

      4,356

      (1,073)

      6,106

      106,629

      937

      107,566

      Loss for the year

      -

      -

      (4,627)

      -

      -

      -

      -

      (4,627)

      (1,541)

      (6,168)

      Other comprehensive income (loss) for the year

      -

      -

      -

      -

      (533)

      1,414

      -

      881

      1,402

      2,283

      Total comprehensive income (loss) for the year

      -

      -

      (4,627)

      -

      (533)

      1,414

      -

      (3,746)

      (139)

      (3,885)

      Transactions with owners of the Company,  recognized directly in equity:











      Issuance of ordinary shares

      3,084

      18,191

      -

      -

      -

      -

      -

      21,275

      -

      21,275

      Options exercise

      20

      -

      -

      -

      -

      -

      -

      20

      -

      20

      Share-based payments

      -

      50

      -

      -

      -

      -

      -

      50

      -

      50

      Balance as at











      December 31, 2020

      25,102

      82,401

      8,191

      (1,736)

      3,823

      341

      6,106

      124,228

      798

      125,026

       

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




      Attributable to shareholders of the Company

      Non- controlling

      Total




      Interests

      Equity


      Share capital

      Share premium

       

       

      Retained earnings

      Treasury shares

      Translation reserve from

      foreign operations

      Hedging Reserve

      Interests Transaction reserve with

      non-controlling Interests

      Total




      Convenience translation into US$ (exchange rate as at March 31, 2021: euro 1 = US$ 1.174)

      For the three month ended March 31, 2021 (unaudited):











      Balance as at January 1, 2021

      29,459

      96,704

      9,613

      (2,037)

      4,487

      400

      7,166

      145,792

      937

      146,729

      Loss for the period

      -

      -

      (2,428)

      -

      -

      -

      -

      (2,428)

      (702)

      (3,130)

      Other comprehensive income (loss) for the period

      -

      -

      -

      -

      655

      (1,960)

      -

      (1,305)

      (1,477)

      (2,782)

      Total comprehensive income (loss) for the period

      -

      -

      (2,428)

      -

      655

      (1,960)

      -

      (3,733)

      (2,179)

      (5,912)

      Transactions with owners of the Company,  recognized directly in equity:











      Buy of shares in subsidiaries from non-controlling interests

      -

      -

      -

      -

      -

      -

      (1,128)

      (1,128)

      1,128

      -

      Warrants exercise

      533

      3,929

      -

      -

      -

      -

      -

      4,462

      -

      4,462

      Options exercise

      26

      -

      -

      -

      -

      -

      -

      26

      -

      26

      Share-based payments

      -

      8

      -

      -

      -

      -

      -

      8

      -

      8

      Balance as at











       March 31, 2021

      30,018

      100,641

      7,185

      (2,037)

      5,142

      (1,560)

      6,038

      145,427

      (114)

      145,313

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Cash Flows


      For the three months
      ended March 31,

      For the year ended
      December 31,

      For the three months
      ended March 31,


      2021

      2020

      2020

      2021


      Unaudited

      Audited

      Unaudited


       

       

      € in thousands

      Convenience
      Translation into US$*

      n thousands

      Cash flows from operating activities





      Loss for the period

      (2,666)

      (1,865)

      (6,168)

      (3,130)

      Adjustments for:





      Financing expenses, net

      2,766

      413

      3,634

      3,247

      Profit from settlement of derivatives contract

      (407)

      -

      -

      (478)

      Depreciation and amortization

      3,051

      726

      2,975

      3,581

      Share-based payment transactions

      7

      14

      50

      8

      Share of profits of equity accounted investees 

      (617)

      (1,331)

      (1,525)

      (724)

      Payment of interest on loan from an equity accounted investee

      -

      582

      582

      -

      Change in trade receivables and other receivables

      (1,182)

      588

      (3,868)

      (1,387)

      Change in other assets

      30

      (215)

      179

      35

      Change in receivables from concessions project

      221

      201

      1,426

      259

      Change in trade payables

      (382)

      315

      190

      (448)

      Change in other payables

      1,596

      (274)

      (1,226)

      1,873

      Income tax expense (tax benefit)

      (319)

      104

      (125)

      (374)

      Income taxes paid

      -

      -

      (119)

      -

      Interest received

      427

      441

      2,075

      501

      Interest paid

      (1,206)

      (168)

      (3,906)

      (1,415)


      3,985

      1,396

      342

      4,678

      Net cash from (used in) operating activities

      1,319

      (469)

      (5,826)

      1,548

      Cash flows from investing activities





      Acquisition of fixed assets

      (25,653)

      (41,414)

      (128,420)

      (30,106)

      Acquisition of subsidiary, net of cash acquired

      -

      -

      (7,464)

      -

      Compensation as per agreement with Erez Electricity Ltd.

      -

      -

      1,418

      -

      Repayment of loan from an equity accounted investee

      -

      1,923

      1,978

      -

      Loan to an equity accounted investee

      (113)

      -

      (181)

      (133)

      Advances on account of investments

      -

      -

      (1,554)

      -

      Settlement of derivatives

      (252)

      -

      -

      (296)

      Proceed from restricted cash, net

      454

      22,585

      23,092

      533

      Proceed from (investment) in short term deposit

      8,533

      -

      (1,323)

      10,014

      Proceeds from marketable securities

      1,785

      -

      1,800

      2,095

      Acquisition of marketable securities

      -

      -

      (1,481)

      -

      Net cash used in investing activities

      (15,246)

      (16,906)

      (112,135)

      (17,893)

      Cash flows from financing activities





      Issuance of warrants

      -

      320

      2,544

      -

      Acquisition of shares in subsidiaries from non-controlling interests

      1,400

      -

      -

      1,643

      Proceeds from options

      22

      -

      20

      26

      Cost associated with long term loans

      (197)

      -

      (734)

      (231)

      Proceeds from long term loans

      27,061

      40,923

      111,357

      31,758

      Repayment of long-term loans

      (457)

      (810)

      (3,959)

      (536)

      Repayment of Debentures

      (21,877)

      (22,162)

      (26,923)

      (25,674)

      Exercise of warrants

      3,675

      13,188

      21,275

      4,313

      Proceeds from issue of convertible debentures, net

      15,571

      -

      -

      18,274

      Proceeds from issuance of Debentures, net

      25,465

      -

      38,057

      29,885

      Net cash from financing activities

      50,663

      31,459

      141,637

      59,458






      Effect of exchange rate fluctuations on cash and cash equivalents

      1,439

      (828)

      (1,340)

      1,688

      Increase in cash and cash equivalents

      38,175

      13,256

      22,336

      44,801

      Cash and cash equivalents at the beginning of the period

      66,845

      44,509

      44,509

      78,448

      Cash and cash equivalents at the end of the period

      105,020

      57,765

      66,845

      123,249


      * Convenience translation into US$ (exchange rate as at March 31, 2021: euro 1 = US$ 1.174)


      Ellomay Capital Ltd. and its Subsidiaries

      Operating Segments


      PV




      Total





      reportable


      Total


      Italy

      Spain

      Israel[1]

      Talasol

      Biogas

      Dorad

      Manara

      segments

      Reconciliations

      consolidated


      For the three months ended March 31, 2021


      € in thousands












      Revenues

      -

      784

      832

      3,089[2]

      3,098

      12,227

      -

      20,030

      (12,830)

      7,200

      Operating expenses

      -

      (132)

      (81)

      (611)

      (2,393)

      (9,279)

      -

      (12,496)

      9,279

      (3,217)

      Depreciation and amortization expenses

       

      -

       

      (237)

       

      (574)

       

      (1,915)

       

      (771)

       

      (1,212)

       

      -

       

      (4,709)

       

      1,658

       

      (3,051)

      Gross profit (loss)

      -

      415

      177

      563

      (66)

      1,736

      -

      2,825

      (1,893)

      932

      Project development costs










      (505)

      General and











       administrative expenses










      (1,263)

      Share of profits (loss) of











       equity accounted investee










      617

      Operating loss










      (219)

      Financing income










      912

      Financing income











       (expenses) in connection











       with derivatives, net










      (124)

      Financing expenses, net










      (3,554)

      Loss before taxes











       on Income










      (2,985)

      Segment assets as at











       March 31, 2021

      588

      18,244

      35,543

      237,886

      36,282

      113,366

      42,859

      484,768

      6,879

      491,647













      ___________

      [1] The Talmei Yosef PV Plant located in Israel is presented under the fixed asset model and not under the financial asset model as per IFRIC 12.

      [2] Not including an amount of approximately €1 million of proceeds from the sale of electricity prior to January 27, 2021 (the date in which the Talasol PV Plant achieved PAC).

      Ellomay Capital Ltd. and its Subsidiaries

      Reconciliation of Loss to EBITDA


      For the three months ended
      March 31,

      For the year
      ended December
      31,

      For the three
      months ended
      March 31,


      2021

      2020

      2020

      2021


      Unaudited


      € in thousands

      Convenience
      Translation into
      US$*
      in thousands

      Net loss for the period

      (2,666)

      (1,865)

      (6,168)

      (3,130)

      Financing expenses, net

      2,766

      413

      3,634

      3,247

      Tax benefit (Taxes on income)

      (319)

      104

      (125)

      (374)

      Depreciation

      3,051

      726

      2,975

      3,581

      EBITDA

      2,832

      (622)

      316

      3,324

      * Convenience translation into US$ (exchange rate as at March 31, 2021: euro 1 = US$ 1.174)

       

      Reconciliation of Segment Gross Profit to Segment Adjusted FFO



      Talasol PV Plant

      Israel – PV(1)


      For the three months ended March
      31, 2021


      Unaudited


      € in thousands

      Gross profit

      563

      177

      General and administrative expenses

      (138)

      (47)

      Operating profit

      425

      130

      Adjustment

      845(2)

      -

      Adjusted operating profit

      1,270

      -

      Depreciation and amortization

      1,915

      574

      Interest on loans

      (1,425)

      (209)

      Adjusted FFO

      1,760

      495




      (1)  Based on the segment results set forth above, which are adjusted to present the results of the Talmei Yosef
      PV Plant based on the fixed asset model and not as a financial asset under IFRIC 12.

      (2)  Results of the Talasol PV Plant for the period until January 27, 2021.

      Reconciliation of Segment Gross Profit (Loss) to Segment FFO





      Spain – PV

      Netherlands –
      Biogas


      For the three months ended March
      31,


      2021


      Unaudited


      € in thousands

      Gross profit (loss)

      509

      (66)

      General and administrative expenses

      (23)

      (27)

      Operating profit (loss)

      486

      (93)

      Depreciation and amortization

      237

      771

      Interest on loans

      (69)

      (109)

      FFO

      654

      569

      Information for the Company's Debenture Holders

      Pursuant to the Deeds of Trust governing the Company's Series C and Series D Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on March 31, 2021 and below.

      Net Financial Debt

      As of March 31, 2021, the Company did not have a Net Financial Debt, as the calculation of Net Financial Debt (as such term is defined in the Deeds of Trust of the Company's Debentures), resulted in a negative amount (i.e., an excess of assets over liabilities) of approximately €(1.2) (consisting of approximately €242.8[1] million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €103.8[2] million in connection with the Series C Debentures issuances (in July 2019,  October 2020 and February 2021) and Series D Debentures issuance (in February 2021), net of approximately €105 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €242.8[3] million of project finance and related hedging transactions of the Company's subsidiaries).

      ___________

      [1] Short-term and long-term debt from banks and other interest bearing financial obligations amount provided above, includes an amount of approximately €12.3 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet. 

      [2] Debentures amount provided above, includes an amount of approximately €2.5 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company's balance sheet. 

      [3] The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).

      Information for the Company's Series C Debenture Holders.

      The Deed of Trust governing the Company's Series C Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of March 31, 2021, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's shareholders' equity was approximately €123.8 million and (ii) the Company did not have a Net Financial Debt. In the event the Company does not have a Net Financial Debt the calculation of the two covenants that are based on Net Financial Debt (i.e., the ratio of the Company's Net Financial Debt to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) and the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA[1]), becomes irrelevant and the Company is therefore in compliance with such covenants.

      The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended March 31, 2021[2]:


      For the four quarter period ended
      March 31, 2021


      Unaudited


      € in thousands

      Loss for the period

      (6,969)

      Financing expenses, net

      5,987

      Taxes on income

      (548)

      Depreciation

      5,300

      Adjustment to revenues of the Talmei Yosef PV Plant due to calculation
      based on the fixed asset model

      3,013

      Share-based payments

      43

      Adjusted EBITDA as defined the Series C Deed of Trust

      6,826

      ___________

      [1] The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      [2] As noted above, the Company is in compliance with the covenant with respect to the ratio of Net Financial Debt to Adjusted EBITDA as the Company does not have a Net Financial Debt as of the end of the period. Therefore, the Adjusted EBITDA calculation above is provided for convenience and consistency purposes only.

      Information for the Company's Series D Debenture Holders

      The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of March 31, 2021, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €118.3 million and (ii) the Company did not have a Net Financial Debt. The Series D Deed of Trust provides that in the event the result of calculation of the Company's Net Financial Debt is a negative amount, the Company is and will be considered to have met the financial covenants that are based on the Net Financial Debt (i.e., the ratio of the Net Financial Debt to the Company's CAP, Net and the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA[8]).  

      The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended March 31, 2021[9]:


      For the four quarter period ended
      March 31, 2021


      Unaudited


      € in thousands

      Loss for the period

      (6,969)

      Financing expenses, net

      5,987

      Taxes on income

      (548)

      Depreciation

      5,300

      Adjustment to revenues of the Talmei Yosef PV Plant due to
      calculation based on the fixed asset model

      3,013

      Share-based payments

      43

      Adjustment to data relating to projects with a Commercial Operation
      Date during the four preceding quarters[10]

      12,366

      Adjusted EBITDA as defined the Series D Deed of Trust

      19,192


      ___________

      [1] The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      [2] As noted above, the Company is in compliance with the covenant with respect to the ratio of Net Financial Debt to Adjusted EBITDA as the Company does not have a Net Financial Debt as of the end of the period. Therefore, the Adjusted EBITDA calculation above is provided for convenience and consistency purposes only.

      [3] The adjustment is based on the results of the Talasol Project since January 27, 2021 and of the biogas plant in Gelderland since January 1, 2021. The results of the biogas plant in Gelderland were not included in the profit and loss statement of the Company for the year ended December 31, 2020.

      SOURCE Ellomay Capital Ltd

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.